Mitogen-activated Protein Kinase (MAPK) Interacting Kinases 1 and 2 (MNK1 and MNK2) as Targets for Cancer Therapy: Recent Progress in the Development of MNK Inhibitors

2017 ◽  
Vol 24 (28) ◽  
Author(s):  
Agnieszka Dreas ◽  
Maciej Mikulski ◽  
Mariusz Milik ◽  
Charles-Henry Fabritius ◽  
Krzysztof Brzózka ◽  
...  
2012 ◽  
Vol 40 (1) ◽  
pp. 79-84 ◽  
Author(s):  
Ivan del Barco Barrantes ◽  
Angel R. Nebreda

Cells from primary tumours need to go through several steps to become fully metastatic. During this process, cancer cells acquire the ability to invade, migrate across the surrounding tissue, enter into the circulation and colonize distant organs. In the present paper, we review recent progress in understanding how the p38 MAPK (mitogen-activated protein kinase) signalling pathway participates in the different steps of metastasis. Experimental evidence suggests that tumour cells need to modulate p38 MAPK activity levels to successfully metastasize.


Proceedings ◽  
2019 ◽  
Vol 22 (1) ◽  
pp. 10
Author(s):  
Pirolli ◽  
Righino ◽  
Tropea ◽  
Gurrieri ◽  
Sangiorgi ◽  
...  

Among all the several targets in common use in the antitumor therapies, the pharmacologicinhibition of the MAPK (Mitogen Activated Protein Kinase) pathway represents an efficienttherapeutic approach [1]. [...]


Sign in / Sign up

Export Citation Format

Share Document